Skip to content

OPTIEK EVELINE

Active
Private limited companyfounded 2020active for 6 yearsStationsstraat 31, 9860 Oosterzele, BelgiumKBO/BCE: BE 0755.422.637
Summary

OPTIEK EVELINE has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €120,725 and a net result of €11,141. Equity is growing by about 26% per year across the filed financial years. Its solvency ranks better than 64% of 782 sector peers (NACE 32, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
Manufacture of medical and dental instruments and supplies
NACE 32500Retail sale of prescription glasses, lenses and sunglasses NACE 47742
1 site
Size
≈ €170,000turnover 2025, estimated
Staff
0.3 FTE
Equity
€120,725
Profit
€11,141
Turnover estimated from the gross margin
Financial health
94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
2025 accounts 16 days early1 deed in the Belgian Official Gazette
Why 94raises riskFounded in 2020lowers riskLiquidity: current ratio 1.85, cash €82,250Sector: Other manufacturing (NACE 32)Equity €120,725 (56.7% of total assets)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 61% of its sector peers (NACE 32, micro)
Financial strength · tick = 2024
Strong
Solvency 82+3
equity 56.7% of total assets
Liquidity 81+15
short-term debt 37.1% · cash 38.7%
Profitability 67-15
return on assets 5.2%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.3% (1,143 companies, NACE 32, micro)
Last 24 months 11-2024: 0.2% 12-2024: 0.2%● unchanged vs 11-2024 01-2025: 0.3%▲ +0.1 percentage points vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025highest value 05-2025: 0.1%▼ -0.2 percentage points vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.2%▲ +0.1 percentage points vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.1%▼ -0.1 percentage points vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026lowest value 07-2026: 0.1%● unchanged vs 06-2026lowest value 08-2026: 0.1%● unchanged vs 07-2026lowest value 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €11,000 on 30-day terms is acceptable
Liquidity ample (current ratio 1.85, compared with 1.83 in 2024, above the usual 1.5; short-term debt: 37.1% and cash: 38.7% of total assets), and 43.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 32, micro): better than 64% on solvency, 80% on liquidity, 41% on profitability and 59% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 1.85, cash €82,250
NBB · annual accounts
lowers risk · Sector: Other manufacturing (NACE 32)
KBO
lowers risk · Equity €120,725 (56.7% of total assets)
NBB · annual accounts
raises risk · Founded in 2020
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 14-04-2026, 16 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
16 days early
2024
30 days early
2023
14 days early
2022
2 days early
2021
30 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 5 accounts on average 6 days before the deadline; the sector median (NACE 32) for financial year 2024 is 2 days before the deadline, and 39% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 17 April (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
30-09-2026 year end30-10-2026 today30-04-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Weakest financial yearnet €11,141 ▼47.3%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Positive: 5 profitable years in a rowprofit 2025: €11,141 5 years View
  • Positive: Filed on time since financial year 2022accounts within the deadline every year 4 years View
  • Total assets 20255 financial years filed €212,786 View

By topic

Financials

Financial year
2025
Total assets
€212,786
Profit
€11,141
Solvency
56.7%
Total assets▲ 5.5%
Net result
20212025
Go to Financials

Timeline

Events
7
Since
2022
Next accounts
by 30-04-2027
  1. 30-09-2024Equity above €100,000
  2. 16-04-2024Annual accounts filed
  3. 28-04-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Manufacture of medical and dental instruments and suppliesNACE 32500
Founded
30-09-2020
Year ends
30-09
Peppol
Reachable for e-invoices
Go to Company details

Key facts about OPTIEK EVELINE

What is the company number of OPTIEK EVELINE?
0755.422.637. In Belgium the VAT number is the company number with BE in front: BE 0755.422.637.
Where is OPTIEK EVELINE based?
The registered office is at Stationsstraat 31, 9860 Oosterzele.Company details
What does OPTIEK EVELINE do?
According to the KBO register, the main activity is manufacture of medical and dental instruments and supplies (NACE 32500).
What is the legal form of OPTIEK EVELINE?
Private limited company (BV).
When was OPTIEK EVELINE founded?
On 30-09-2020.
Is OPTIEK EVELINE still active?
Yes, OPTIEK EVELINE is an active enterprise in the KBO register.
How many employees does OPTIEK EVELINE have?
On average 0.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of OPTIEK EVELINE?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is OPTIEK EVELINE profitable?
In financial year 2025, OPTIEK EVELINE made a profit of €11,141.
Where can I find the annual accounts of OPTIEK EVELINE?
OPTIEK EVELINE filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of OPTIEK EVELINE due?
By 30-04-2027, for financial year 2026.Timeline

Companies related to OPTIEK EVELINE

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.